Tag | Content |
---|
EnhancerAtlas ID | HS074-00265 |
Organism | Homo sapiens |
Tissue/cell | GM19239 |
Coordinate | chr1:28453480-28454800 |
Target genes | Number: 17 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SPI1 | MA0080.4 | chr1:28454307-28454321 | AGAAAGGGGAAGTG | + | 6.22 | SPIB | MA0081.2 | chr1:28454309-28454321 | AAAGGGGAAGTG | + | 6.07 | STAT1 | MA0137.3 | chr1:28454538-28454549 | TTTCTGGGAAA | + | 6.02 | STAT3 | MA0144.2 | chr1:28454538-28454549 | TTTCTGGGAAA | + | 6.32 | Stat4 | MA0518.1 | chr1:28454538-28454552 | TTTCTGGGAAATCA | + | 6.2 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_09203 | chr1:28451257-28456311 | CD14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr1 | 28453663 | 28453991 | chr1 | 28454216 | 28454379 | chr1 | 28453901 | 28454800 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I028125 | chr1 | 28451912 | 28456370 |
|
Enhancer Sequence | ATATCTCAGA AAAGAGAAGT AGCAGCAGTT GACAGGAAGA GCAACATCCT CAATTTTCAA 60 GATATTTACA AAGTTTGTGT GTGTTTTTCT CTTCCTAAGT TCCCTCTTCA AAGAAAATTA 120 TTCCTCCCCA GTTCCAATAA ACTTTTGCTG ACCAGCACAA CCTGTCCACC TTTGCTATTA 180 AAGGGACAAA AAGTAAGTCA GCTATGAGGC ACCTTATATA TTAGTAAAAA CTAAAAATAA 240 TTATAACAGT CAGTGCTGGC AAGGATATGA CAAAACTAGT ATTTACATAA TTTGCTGGTG 300 GTGGTGTAAC TGTCACAACC CTTCAAAAAG AACTTTGGCA ATATATTTCA CCGGGTGGTA 360 ATTCCTTTCC CAGAACTTTA TTATAACTAA ATTATAATAA AGGGGAAACA AAGTAGCAAA 420 AACCTGGAAA TGACTTGCAT GTCACGTGTT TTGAGCACTT ACTTTGTAGC AGGTTCTATG 480 TTATACACTC AACACAAATA ATCTCATTTA ATCCTCAAAA CAATTCTAGG AGGGATATGC 540 TATTTTACTC CTTGTATTCT GAATGGGGAA ACTGGGACTA CAAGGAATAA AGTAATTTTC 600 CCATGGCTCA ACAGCTGTAG GGCAAGGGAG GGTTTAAATC ATTGAGGAAC AATGAAGATA 660 CAGAATTCTT CTTCCTTCTA CAGTAGTGTA TGGAGAAGGG GCATGGATGG CCACTTCTCA 720 AGCCTCTACA ATGTGCTAGT TACTGTAGAT TGGTTGTCTC ATTAAAGCCT CTCATCTTCA 780 AGATAGGAGA TCAATAGACT CTTTGACAAG TGTGGAAACT GATACTAAGA AAGGGGAAGT 840 GGTCAACTCA GTCAGACAAC AAGTGATCAC TGTCCCAGAA TTCTAGCCCA GCATGTCTGA 900 TTCTAGAGTC CATGCTCCTT CCTCAGGCTG TCTCTTTAAG AAAGACTCAA AATATAGTAA 960 CTGAAGTCAA TTCAGGCATG GGGAATGTTG GGCTGGTGGA GATGGGGAGG ATGTTTGACC 1020 GCTGAGCCTA GAGGACACTG ACCTATCTCC AGAGGCACTT TCTGGGAAAT CAGACAGCCC 1080 TAGGTTTGGG ATCCAAGGAG GAGTGGGAAC ATGGTATAGC CTTAGCAGGT CTTTAACCGA 1140 GGCAGCTAAG AGGCAGGTAA TATGCAAAGT CTGAGGCTAT GTTCAGTCAC AACTGGAGAA 1200 CTAAATAGAA AAATTGAGGC AGAATCTCAG TCAAGGACCA TAGCAGCATG GGAGAAGAAG 1260 AAGACGGCAG CATTGTGATT TGTGGGTTTC CAGAAGTACC CTCCAATACT CCATGGCCTT 1320
|